Stay updated on Upadacitinib in Active Ankylosing Spondylitis Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib in Active Ankylosing Spondylitis Clinical Trial page.

Latest updates to the Upadacitinib in Active Ankylosing Spondylitis Clinical Trial page
- ChecktodayChange DetectedA new publication citation was added to the study's Publications section, describing extramusculoskeletal manifestations in upadacitinib-treated patients with Psoriatic Arthritis or Axial Spondyloarthritis.SummaryDifference0.0%

- Check7 days agoChange DetectedThe page now shows Revision: v3.6.6, replacing the previous Revision: v3.6.5. This indicates a minor update to the page's build/metadata rather than any change to the study content.SummaryDifference0.0%

- Check14 days agoChange DetectedAn additional line, '2017 ( U.S. NIH Grant/Contract )', was added after the EudraCT Number in the study's identifiers. This indicates the U.S. NIH funding source for the project.SummaryDifference0.0%

- Check29 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, signaling a new release of the page template. No study-related content appears to have changed.SummaryDifference0.0%

- Check51 days agoChange DetectedThe site's revision label was updated from v3.6.3 to v3.6.4, indicating a new build was deployed.SummaryDifference0.0%

- Check72 days agoChange DetectedRevision tag in the site metadata has been updated from v3.6.0 to v3.6.3. This is a minor platform update and does not alter visible content or user-facing functionality.SummaryDifference0.0%

Stay in the know with updates to Upadacitinib in Active Ankylosing Spondylitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib in Active Ankylosing Spondylitis Clinical Trial page.